• »

Leverage Your Profits With
"The Survivors"

The bear market has mauled many stocks so badly that investors have given them up for dead. And that’s the source of a huge opportunity.

Some of those wounded and bleeding companies are destined to survive — and heal. And a select few will double, triple and even quadruple over the next two or three years.

I’m not saying these "survivor stocks" are for everyone. There’s a risk that some of them will run into financial or operational barriers that prevent a recovery — you could still lose most or all of your investment.

Nonetheless, I’m convinced the odds of an economic rebound have improved enough to make it worth betting on a handful of turnaround stories. As long as you carefully limit your exposure (no more than 1% of your portfolio in each stock, and no more than 5% in the whole package), you may find that the rewards outweigh the risks by a wide margin.

Here are five of my favorite turnaround candidates…

NEXT: Stock #1: Abbott Laboratories (ABT)